Anti-Saccharomyces cerevisiae antibodies in Japanese patients with inflammatory bowel disease: diagnostic accuracy and clinical value.
about
Inflammatory bowel disease in Asia: A systematic reviewAntibody markers in the diagnosis of inflammatory bowel diseaseThe association between race and Crohn's disease phenotype in the Western Cape population of South Africa, defined by the Montreal Classification SystemSerological markers (anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic antibodies) in inflammatory bowel disease: diagnostic utility and phenotypic correlation.Molecular cloning reveals nearly half of patients with Crohn's disease have an antibody to peroxiredoxin 6-like protein.The utility of apoptosis inhibitor of macrophages as a possible diagnostic marker in patients with Crohn's disease.IBD serological panels: facts and perspectives.Inflammatory bowel disease serology in Asia and the West.New serological biomarkers of inflammatory bowel disease.Noninvasive methods in evaluation of inflammatory bowel disease: where do we stand now? An update.Serological antibodies in inflammatory bowel disease: a systematic review.Ethnic and socio-cultural specificities in Tunisia have no impact on the prevalence of anti-Saccharomyces cerevisiae antibodies in Crohn's disease patients, their relatives or associated clinical factors.Anti-high mobility group box 1 and box 2 non-histone chromosomal proteins (HMGB1/HMGB2) antibodies and anti-Saccharomyces cerevisiae antibodies (ASCA): accuracy in differentially diagnosing UC and CD and correlation with inflammatory bowel disease pPossible diagnostic role of antibodies to Crohn's disease peptide (ACP): results of a multicenter study in a Japanese cohort.Anti-Saccharomyces cerevisiae antibodies associate with phenotypes and higher risk for surgery in Crohn's disease: a meta-analysis.Isolated active ileitis: is it a mild subtype of Crohn's disease?Combining TNFSF15 and ASCA IgA can be used as a predictor for the stenosis/perforating phenotype of Crohn's disease.Seroreactivity to microbial components in Crohn's disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patients.Diagnostic utility of serological biomarkers in patients with Crohn's disease: A case-control study
P2860
Q22242420-F5CE0384-337D-46F4-A8F9-468EEA286D56Q26774452-83E4DDBA-7287-4370-982E-FF3F73248944Q34035520-1BBB3926-D938-459A-AA1A-C7762C76B555Q34143593-5721CBFA-3016-47BC-8819-51782591E32AQ34230939-12BC4B98-E135-48F8-A5BD-7320E1A2F642Q36305141-23B13513-085C-4E03-BBFB-DBCA3B722F7CQ36884782-E5E6955F-9FC9-4D8A-907A-25328950D878Q37208122-2FBFDF64-E819-4B83-9D52-F4CB73FB6EA3Q37262989-42F00EFF-D75E-4F6B-AA8E-C4FA1FF72170Q37698973-BF89175B-DC0E-4239-8857-8DE95197AFE5Q37954231-A2E50BAB-1702-4101-9E45-83C791991D05Q39040664-245D159B-2B87-4EB5-8F23-80509BA50D8BQ43438189-D3F60D48-99C1-4415-ABC3-05861F7F7CECQ46053703-95A20F9E-D6AD-4667-BEA9-2BC0E7AC88C6Q47661706-18C5D5FA-A9AA-4128-8CF7-44E3F005D5A0Q50921326-CED1586F-C719-479C-B74A-098E6112445FQ54119470-2A6FB6C0-394A-4E12-A755-BBC16534E3D1Q54443565-54049B26-DA71-472B-BF80-4A80EA8B10AEQ58789070-C2A87AC2-2E24-461B-B93E-C9FC4467F00F
P2860
Anti-Saccharomyces cerevisiae antibodies in Japanese patients with inflammatory bowel disease: diagnostic accuracy and clinical value.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Anti-Saccharomyces cerevisiae ...... c accuracy and clinical value.
@en
Anti-Saccharomyces cerevisiae ...... c accuracy and clinical value.
@nl
type
label
Anti-Saccharomyces cerevisiae ...... c accuracy and clinical value.
@en
Anti-Saccharomyces cerevisiae ...... c accuracy and clinical value.
@nl
prefLabel
Anti-Saccharomyces cerevisiae ...... c accuracy and clinical value.
@en
Anti-Saccharomyces cerevisiae ...... c accuracy and clinical value.
@nl
P2093
P356
P1476
Anti-Saccharomyces cerevisiae ...... c accuracy and clinical value.
@en
P2093
Akinori Iwashita
Hiroaki Matake
Hiroshi Tanabe
Shino Kamachi
Takashi Hisabe
Toshihiro Sakurai
Toshiyuki Matsui
Tsuneyoshi Yao
Yuji Murakami
P304
P356
10.1007/S005350300020
P577
2003-01-01T00:00:00Z